AR056500A1 - Metodo para preparar una composicion medica - Google Patents

Metodo para preparar una composicion medica

Info

Publication number
AR056500A1
AR056500A1 ARP060103874A ARP060103874A AR056500A1 AR 056500 A1 AR056500 A1 AR 056500A1 AR P060103874 A ARP060103874 A AR P060103874A AR P060103874 A ARP060103874 A AR P060103874A AR 056500 A1 AR056500 A1 AR 056500A1
Authority
AR
Argentina
Prior art keywords
preparing
composition
medical composition
treatment
viscosity
Prior art date
Application number
ARP060103874A
Other languages
English (en)
Inventor
Peter Charles Molan
Original Assignee
Waikatolink Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37836076&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR056500(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Waikatolink Ltd filed Critical Waikatolink Ltd
Publication of AR056500A1 publication Critical patent/AR056500A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Medical Informatics (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Método para preparar una composicion médica, el cual incluye los siguientes pasos: preparar una composicion para tratamiento, y agregar al menos un agente para aumentar la viscosidad a la composicion para tratamiento, caracterizado porque los agentes para aumentar la viscosidad tienen la propiedad de aumentar al menos mantener la viscosidad de la composicion para tratamiento después de que se aplica a una herida.
ARP060103874A 2005-09-06 2006-09-06 Metodo para preparar una composicion medica AR056500A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ542258A NZ542258A (en) 2005-09-06 2005-09-06 A medical composition comprising honey or sugar syrup and a viscosity increasing agent for use on wounds

Publications (1)

Publication Number Publication Date
AR056500A1 true AR056500A1 (es) 2007-10-10

Family

ID=37836076

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060103874A AR056500A1 (es) 2005-09-06 2006-09-06 Metodo para preparar una composicion medica

Country Status (11)

Country Link
US (1) US20090148537A1 (es)
EP (1) EP1933858A4 (es)
JP (1) JP2009507069A (es)
CN (1) CN101277709A (es)
AR (1) AR056500A1 (es)
AU (1) AU2006288017B2 (es)
CA (1) CA2621774A1 (es)
CL (1) CL2006002332A1 (es)
NZ (1) NZ542258A (es)
PE (1) PE20070525A1 (es)
WO (1) WO2007030023A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0813541D0 (en) * 2008-07-24 2008-08-27 Brightwake Ltd Honey wound dressing
US20120021061A1 (en) * 2008-12-24 2012-01-26 Comvita New Zealand Limited Medical and nutritional formulations
AU2013202868B2 (en) * 2010-05-05 2015-03-26 Comvita New Zealand Limited Immunostimulatory compositions and methods of use thereof
WO2011139168A1 (en) * 2010-05-05 2011-11-10 Comvita New Zealand Limited Immunostimulatory compositions and methods of use thereof
ITRM20120555A1 (it) * 2012-11-13 2014-05-14 Aboca Spa Societa Agricola Enteroclismi.
JP2016529291A (ja) 2013-09-02 2016-09-23 ハニーラボ リミテッド 蜂蜜組成物
US10342891B2 (en) 2013-09-19 2019-07-09 Medline Industries, Inc. Wound dressing containing saccharide and collagen
US10086017B2 (en) 2013-09-19 2018-10-02 Medline Industries, Inc. Wound dressing containing polysaccharides
BR112016025331A2 (pt) 2014-04-30 2017-08-15 Matoke Holdings Ltd composições antimicrobianas
CN106692190A (zh) * 2017-01-25 2017-05-24 天津嘉氏堂科技有限公司 一种具有创面修护作用的组合物及制备方法
GB2566951A (en) * 2017-09-27 2019-04-03 Brightwake Ltd Compositions for wound treatment
GB201716986D0 (en) 2017-10-16 2017-11-29 Matoke Holdings Ltd Antimicrobial compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3827561C1 (es) * 1988-08-13 1989-12-28 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
US5078313A (en) * 1990-07-11 1992-01-07 Sweetheart Cup Company Inc. Wax-coated paperboard containers
JP3583166B2 (ja) * 1994-06-27 2004-10-27 興和株式会社 損傷皮膚修復用粉末製剤
EP1197085A1 (en) * 1999-07-16 2002-04-17 United Video Properties, Inc. Interactive television program guide with selectable languages
CN1409636A (zh) * 1999-12-09 2003-04-09 威凯托陵科有限公司 蜂蜜基伤口敷料
AU2001244892A1 (en) * 2000-03-17 2001-09-24 Phillip Roy Caskey Improvements in and relating to honey based products
NL1016398C2 (nl) * 2000-10-13 2002-04-16 Triticum Exploitatie B V Samenstelling op basis van een therapeutisch actieve verbinding, in het bijzonder honing, voor het behandelen van wonden.
GB0110715D0 (en) * 2001-05-02 2001-06-27 Acordis Speciality Fibres Ltd Wound dressing
WO2005077402A1 (en) * 2004-02-11 2005-08-25 Virchow Biotech Private Limited Honey based gel formulations

Also Published As

Publication number Publication date
EP1933858A1 (en) 2008-06-25
PE20070525A1 (es) 2007-07-13
US20090148537A1 (en) 2009-06-11
WO2007030023A1 (en) 2007-03-15
AU2006288017B2 (en) 2012-04-19
CL2006002332A1 (es) 2008-02-22
EP1933858A4 (en) 2009-09-30
AU2006288017A1 (en) 2007-03-15
NZ542258A (en) 2010-05-28
JP2009507069A (ja) 2009-02-19
CA2621774A1 (en) 2007-03-15
CN101277709A (zh) 2008-10-01

Similar Documents

Publication Publication Date Title
AR056500A1 (es) Metodo para preparar una composicion medica
AR109263A2 (es) Composición que comprende moxidectina
AR068867A1 (es) Composiciones de fluido para tratamianto de pozos que incluyen una formulacion de percarbonato de liberacion retardada y metodos para usarlas
AR109605A2 (es) Método para tratar enfermedades vasculares periféricas, composición y utilización
AR068185A1 (es) Composiciones de tabletas de desintegracion oral de lamotrigina
ECSP10010106A (es) Trans-clomifeno para el síndrome metabólico
CL2008000893A1 (es) Composición para el cuidado bucal que comprende una cantidad efectiva de un aminoácido básico y un agente antibacteriano; uso en el tratamiento antibacteriano de la cavidad bucal.
HN2006000971A (es) Metodos para preparar composiciones o formas de dosificacion que comprenden un agonista grp119 que tiene el efecto de un secretagogo glp-1
BRPI0822885A2 (pt) Implemento para cuidado oral, método para administrar um agente ativo, e, kit para cuidado oral
UY33700A (es) ?combinaciones farmacéuticas para el tratamiento de trastornos metabólicos?.
BRPI0513812B8 (pt) método para produzir uma composição líquida que compreende 13c-piruvato hiperpolarizado, composição, uso da mesma, radical, e, uso do radical
CO6300964A2 (es) Una composicion farmaceutica que comprende una combinacion de un agente quimioterapeutico y un anticuerpo 3 antiglipicano
AR071183A1 (es) Composicion oral que comprende un componente activo y un componente formador de pelicula adhesiva, metodo
AR092330A1 (es) Composiciones, metodos de absorcion transmucosa y metodo de tratamiento
CL2009000625A1 (es) Composicion farmaceutica que comprende a)un primer poliol seleccionado de manitol, sorbitol o una combinacion de ambos, b)segundo poliol seleccionado de propilenglicol, glicerina o una combinacion de ambas, c)complejo de borato en un 0,5% p/v de la composicion total, d)preservante, e)agua; util para el tratamiento del ojo.
CL2007003331A1 (es) Metodo para tratar cancer mediante la administracion de un agente radiosensibilizante derivado de benzo[a]trinden-4,6-diona; composicion farmaceutica que comprende dicho agente.
CL2010001406A1 (es) Composicion farmaceutica oftalmica que comprende povidona yodada, y un compuesto antiinflamatorio esteroidal, un compuesto antiinflamatorio no esteroidal, un antibacteriano, un antialergico o un compuesto antiglaucoma; y metodo para preservar la composicion.
ECSP088793A (es) Combinación Farmacéutica que comprende 3-(3-dimetilamino-1etil-2-metil-propil)-fenol y Paracetamo
CL2007002026A1 (es) Composicion que comprende al menos un compuesto quelante de hierro y al menos un agente antifungico; y metodo para el tratamiento o prevencion de una condicion fungica.
CL2009000803A1 (es) Uso de una variante de igf-1 pegilada para tratar, prevenir un trastorno neuromuscular; metodo para el tratamiento, prevencion y/o demora de un trastorno neuromuscular; composicion que comprende la variante de igf-1 modificada
CL2012001835A1 (es) Uso de una formulacion que comprende un agente viscogenico y moxifloxacina para preparar un medicamento util para tratar el oido medio.
BRPI0908139A2 (pt) Agente de formação de espuma para uma composição de dentifrício, composição de centifrício, e, método para tratamento e/ou alívio de xerostomia
AR087790A1 (es) Uso de un inhibidor de aromatasa para el tratamiento de hipogonadismo y enfermedades relacionadas
AR091739A1 (es) Composiciones y metodos para reducir el riesgo cardiometabolico
CL2009000844A1 (es) Metodo para tratar cancer en un paciente que comprende la administracion de un primer agente que es inhibidor de factor de crecimiento de hepatocito (hgf) en combinacion con un segundo agente que es agonista de pten.

Legal Events

Date Code Title Description
FB Suspension of granting procedure